Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01672840 · ClinicalTrials.gov registry record · NA
Effects of Cocoa on Ambulatory Blood Pressure and Vascular Function in Patients With Stage I Hypertension
A NA study, sponsored by Griffin Hospital.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT01672840 is a NA study that has completed, run by Griffin Hospital. The registered enrollment target is 120 participants.
The verdict
NCT01672840, a NA study, has completed, sponsored by Griffin Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
The proposed study Dose And Response to Cocoa (DARC), will examine variation in dose of cocoa-containing product consumption over an 8-week period and assess effects on blood pressure, endothelial function and arterial stiffness. The randomized, controlled, modified Latin square parallel design will compare the effects of two doses of cocoa consumption on blood pressure, endothelial function and arterial stiffness in 120 adults with stage 1 hypertension.
Interventions
- DIETARY_SUPPLEMENT 5g Cocoa Consumption
- DIETARY_SUPPLEMENT 10g Cocoa Consumption
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2012-07 |
| Est. Completion | 2013-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01672840
The ClinicalTrials.gov registry entry for NCT01672840 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Griffin Hospital, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 5g Cocoa Consumption is the first listed.
NCT01672840 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01672840 about?
NCT01672840 is a clinical study titled "Effects of Cocoa on Ambulatory Blood Pressure and Vascular Function in Patients With Stage I Hypertension". The proposed study Dose And Response to Cocoa (DARC), will examine variation in dose of cocoa-containing product consumption over an 8-week period and assess effects on blood pressure, endothelial function and arterial stiffness. The randomized, controlled, modified Latin square parallel design will...
What is the current status of trial NCT01672840?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2012-07. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01672840?
The interventions under investigation include: 5g Cocoa Consumption (DIETARY_SUPPLEMENT), 10g Cocoa Consumption (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01672840?
This trial is sponsored by Griffin Hospital, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.